Diagnosis of systemic metastatic retinal lymphoma

Acta Ophthalmologica

Volumn 89, Issue 2, 2011, Pages

  Cao, Xiaoguang ^a,b   Shen, Defen ^a   Callanan, David G ^c   Mochizuki, Manabu ^d   Chan, Chi Chao ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c TEXAS RETINA ASSOCIATES   (United States)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cytokine; IgH gene rearrangement; Intraocular lymphoma; Systemic metastatic retinal lymphoma; Tcr gene rearrangement

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 10; INTERLEUKIN 6; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BLOOD; BLURRED VISION; BREAST; CECUM; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ILEUM; IRIDOCYCLITIS; LYMPHOMA; LYMPHOMA CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; NASOPHARYNX; PRIORITY JOURNAL; RETINA VASCULITIS; RETROPERITONEUM; RETROSPECTIVE STUDY; SKIN; STOMACH; SYSTEMIC METASTATIC RETINAL LYMPHOMA; T CELL LYMPHOMA; TESTIS; VITREOUS BODY;

ADULT; AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; INTERLEUKIN-10; INTERLEUKIN-6; LYMPHATIC METASTASIS; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; RETINAL NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 79952213068     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01797.x     Document Type: Article

References (67)

1. Aozasa K, Takakuwa T, Hongyo T & Yang WI (2008): Nasal NK/T-cell lymphoma: epidemiology and pathogenesis. Int J Hematol 87: 110-117.
2. Baehring JM, Androudi S, Longtine JJ, Betensky RA, Sklar J, Foster CS & Hochberg FH (2005): Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma. Cancer 104: 591-597. (Pubitemid 41022817)
3. Bardenstein DS (1998): Intraocular lymphoma. Cancer Control 5: 317-325.
4. Blay JY, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, Banchereau J & Favrot MC (1993): Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood 82: 2169-2174. (Pubitemid 23294002)
5. Bogdan C, Vodovotz Y & Nathan C (1991): Macrophage deactivation by interleukin 10. J Exp Med 174: 1549-1555.
6. Buggage RR (2003): Ocular manifestations of human T-cell lymphotropic virus type 1 infection. Curr Opin Ophthalmol 14: 420-425.
7. Calfa CJ, Lossos IS, Ruiz P & Davis JL (2007): Ocular involvement as the initial manifestation of T-cell chronic lymphocytic leukemia. Am J Ophthalmol 144: 326-329. (Pubitemid 47094711)
8. Campo E, Gaulard P, Zucca E et al. (1998): Report of the European Task Force on Lymphomas: workshop on peripheral T-cell lymphomas. Ann Oncol 9: 835-843. (Pubitemid 28440441)
9. Cassoux N, Giron A, Bodaghi B et al. (2007): IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Invest Ophthalmol Vis Sci 48: 3253-3259. (Pubitemid 351261171)
10. Chan JW (2003): Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol 48: 12-38.
11. Chan CC & Gonzales JA (2007): Primary intraocular lymphoma. Singapore: World Scientific Publishing Co. Pte. Ltd.
12. Chan CC & Wallace DJ (2004): Intraocular lymphoma: update on diagnosis and management. Cancer Control 11: 285-295.
13. Chan CC, Whitcup SM, Solomon D & Nussenblatt RB (1995): Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol 120: 671-673.
14. Chan CC, Gonzales JA & Hidayat AA (2008): Intraocular lymphoproliferations simulating uveitis. In: Albert DM & Miller JW (eds) Principles and practice of ophthalmology. New York: Saunders-Elsevier, 1255-1280.
15. Char DH, Ljung BM, Deschenes J & Miller TR (1988): Intraocular lymphoma: immunological and cytological analysis. Br J Ophthalmol 72: 905-911. (Pubitemid 19022865)
16. Cheung MM, Chan JK, Lau WH, Foo W, Chan PT, Ng CS & Ngan RK (1998): Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 16: 70-77. (Pubitemid 28041581)
17. Chong DY, Johnson MW, Shen D, Chan CC & Callanan DG (2009): Vitreous metastases of primary cutaneous B-cell lymphoma. Ocul Immunol Inflamm 17: 342-344.
18. Cimino L, Chan CC, Shen D et al. (2009): Ocular involvement in nasal natural killer T-cell lymphoma. Int Ophthalmol 29: 275-279.
19. Cortes J & Kurzrock R (1997): Interleukin-10 in non-Hodgkin's lymphoma. Leuk Lymphoma 26: 251-259. (Pubitemid 27401908)
20. Coupland SE & Damato B (2008): Understanding intraocular lymphomas. Clin Experiment Ophthalmol 36: 564-578.
21. Coupland SE, Foss HD, Assaf C et al. (1999): T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Ophthalmology 106: 2109-2120. (Pubitemid 30194233)
22. Coupland SE, Hummel M, Muller HH & Stein H (2005): Molecular analysis of immunoglobulin genes in primary intraocular lymphoma. Invest Ophthalmol Vis Sci 46: 3507-3514. (Pubitemid 44264650)
23. Coupland SE, Chan CC & Smith J (2009): Pathophysiology of retinal lymphoma. Ocul Immunol Inflamm 17: 227-237.
24. Criscione VD & Weinstock MA (2007): Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol 143: 854-859. (Pubitemid 47076482)
25. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M & Trinchieri G (1993): Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178: 1041-1048. (Pubitemid 23260442)
26. Doll DC & Weiss RB (1986): Malignant lymphoma of the testis. Am J Med 81: 515-524. (Pubitemid 16003877)
27. Ferguson TA, Green DR & Griffith TS (2002): Cell death and immune privilege. Int Rev Immunol 21: 153-172. (Pubitemid 34791938)
28. Ferry JA, Harris NL, Young RH, Coen J, Zietman A & Scully RE (1994): Malignant lymphoma of the testis, epididymis, and spermatic cord. A clinicopathologic study of 69 cases with immunophenotypic analysis. Am J Surg Pathol 18: 376-390. (Pubitemid 24093602)
29. Filippini A, Riccioli A, Padula F et al. (2001): Control and impairment of immune privilege in the testis and in semen. Hum Reprod Update 7: 444-449. (Pubitemid 32827543)
30. Freeman C, Berg JW & Cutler SJ (1972): Occurrence and prognosis of extranodal lymphomas. Cancer 29: 252-260.
31. Freeman LN, Schachat AP, Knox DL, Michels RG & Green WR (1987): Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology 94: 1631-1639. (Pubitemid 18006894)
32. Gaal K, Sun NC, Hernandez AM & Arber DA (2000): Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol 24: 1511-1517.
33. Gonzales JA & Chan CC (2007): Biopsy techniques and yields in diagnosing primary intraocular lymphoma. Int Ophthalmol 27: 241-250. (Pubitemid 47029020)
34. Harabuchi Y, Takahara M, Kishibe K, Moriai S, Nagato T & Ishii H (2009): Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features. Int J Clin Oncol 14: 181-190.
35. Harris NL, Jaffe ES, Stein H et al. (1994): A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84: 1361-1392. (Pubitemid 24273002)
36. Ho FC, Todd D, Loke SL, Ng RP & Khoo RK (1984): Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight-year period. Int J Cancer 34: 143-148. (Pubitemid 14053133)
37. Hodge DR, Hurt EM & Farrar WL (2005): The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 41: 2502-2512. (Pubitemid 41540626)
38. Horn F, Henze C & Heidrich K (2000): Interleukin-6 signal transduction and lymphocyte function. Immunobiology 202: 151-167. (Pubitemid 30642514)
39. Kumar SR, Gill PS, Wagner DG, Dugel PU, Moudgil T & Rao NA (1994): Human T-cell lymphotropic virus type I-associated retinal lymphoma. A clinicopathologic report. Arch Ophthalmol 112: 954-959. (Pubitemid 24228256)
40. Levy-Clarke GA, Buggage RR, Shen D, Vaughn LO, Chan CC & Davis JL (2002): Human T-cell lymphotropic virus type-1 associated t-cell leukemia/lymphoma masquerading as necrotizing retinal vasculitis. Ophthalmology 109: 1717-1722. (Pubitemid 35006405)
41. Levy-Clarke GA, Chan CC & Nussenblatt RB (2005): Diagnosis and management of primary intraocular lymphoma. Hematol Oncol Clin North Am 19: 739-749. viii.
42. Levy-Clarke GA, Greenman D, Sieving PC, Byrnes G, Shen D, Nussenblatt R & Chan CC (2008): Ophthalmic manifestations, cytology, immunohistochemistry, and molecular analysis of intraocular metastatic T-cell lymphoma: report of a case and review of the literature. Surv Ophthalmol 53: 285-295. (Pubitemid 351685723)
43. Lopez-Guillermo A, Cid J, Salar A et al. (1998): Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. Ann Oncol 9: 849-855. (Pubitemid 28440443)
44. Merle-Beral H, Davi F, Cassoux N, Baudet S, Colin C, Gourdet T, Bodaghi B & LeHoang P (2004): Biological diagnosis of primary intraocular lymphoma. Br J Haematol 124: 469-473. (Pubitemid 38230591)
45. Mochizuki M & Singh AD (2009): Epidemiology and clinical features of intraocular lymphoma. Ocul Immunol Inflamm 17: 69-72.
46. Murphy A, O'Keane JC, Blayney A & Powell FC (1998): Cutaneous presentation of nasal lymphoma: a report of two cases. J Am Acad Dermatol 38: 310-313. (Pubitemid 28115238)
47. Murray PI, Hoekzema R, van Haren MA, de Hon FD & Kijlstra A (1990): Aqueous humor interleukin-6 levels in uveitis. Invest Ophthalmol Vis Sci 31: 917-920. (Pubitemid 20186103)
48. Parikh AH, Khan SH, Wright JD Jr & Oh KT (2005): Systemic non-Hodgkin's lymphoma simulating primary intraocular lymphoma. Am J Ophthalmol 139: 573-574. (Pubitemid 40379105)
49. Rudiger T, Weisenburger DD, Anderson JR et al. (2002): Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 13: 140-149. (Pubitemid 34436738)
50. Sen HN, Bodaghi B, Hoang PL & Nussenblatt R (2009): Primary intraocular lymphoma: diagnosis and differential diagnosis. Ocul Immunol Inflamm 17: 133-141.
51. Shahab N & Doll DC (1999): Testicular lymphoma. Semin Oncol 26: 259-269. (Pubitemid 29272894)
52. Shen DF, Zhuang Z, LeHoang P, Boni R, Zheng S, Nussenblatt RB & Chan CC (1998): Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology 105: 1664-1669. (Pubitemid 28513518)
53. Shibata K, Shimamoto Y, Nishimura T, Okinami S, Yamada H & Miyahara M (1997): Ocular manifestations in adult T-cell leukemia/lymphoma. Ann Hematol 74: 163-168. (Pubitemid 27198786)
54. Singh AD, Lewis H, Schachat AP & Peereboom D (2007): Lymphoma of the retina and CNS. In: Singh AD, Damato BE, Pe'er J, Murphree AL & Perry JD (eds) Clinical ophthalmic oncology. Philadelphia: Saunders-Elsevier 372-377.
55. Smith BD, Smith GL, Cooper DL & Wilson LD (2005): The cutaneous B-cell lymphoma prognostic index: a novel prognostic index derived from a population-based registry. J Clin Oncol 23: 3390-3395.
56. Smith BD, Jones G & Wilson LD (2009): Mycosis fungoides. In: Gunderson LL & Tepper JE (eds) Clinical radiation oncology. Philadelphia, PA: Churchill Livingstone 1773-1798.
57. Streilein JW (2003): Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 3: 879-889.
58. Turner RR, Colby TV & MacKintosh FR (1981): Testicular lymphomas: a clinicopathologic study of 35 cases. Cancer 48: 2095-2102. (Pubitemid 12231568)
59. Velez G, de Smet MD, Whitcup SM, Robinson M, Nussenblatt RB & Chan CC (2000): Iris involvement in primary intraocular lymphoma: report of two cases and review of the literature. Surv Ophthalmol 44: 518-526. (Pubitemid 30440784)
60. de Waal Malefyt R, Haanen J, Spits H et al. (1991): Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174: 915-924.
61. Wallace DJ, Altemare CR, Shen DF, deSmet MD, Buggage RR, Nussenblatt RB & Chan CC (2006): Primary testicular and intraocular lymphomas: two case reports and a review of the literature. Surv Ophthalmol 51: 41-50. (Pubitemid 43083372)
62. Whitcup SM, de Smet MD, Rubin BI, Palestine AG, Martin DF, Burnier M Jr, Chan CC & Nussenblatt RB (1993): Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology 100: 1399-1406.
63. Whitcup SM, Stark-Vancs V, Wittes RE, Solomon D, Podgor MJ, Nussenblatt RB & Chan CC (1997): Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Arch Ophthalmol 115: 1157-1160. (Pubitemid 27387952)
64. Whitcup SM, Chan CC, Buggage RR, Nussenblatt RB, Byrnes GA & Rubin BI (2000): Improving the diagnostic yield of vitrectomy for intraocular lymphoma. Arch Ophthalmol 118: 446. (Pubitemid 30152401)
65. Wolf LA, Reed GF, Buggage RR, Nussenblatt RB & Chan CC (2003): Vitreous cytokine levels. Ophthalmology 110: 1671-1672.
66. Woolley PV III, Osborne CK, Levi JA, Wiernik PH & Canellos GP (1976): Extranodal presentation of non-Hodgkin's lymphomas in the testis. Cancer 38: 1026-1035.
67. Yamanaka N, Kataura A, Sambe S, Minase T & Ishii Y (1985): Midfacial T cell lymphoma: characterization by monoclonal antibodies. Ann Otol Rhinol Laryngol 94: 207-211. (Pubitemid 15096800)